Imagion (ASX:IBX) share price zips 38% higher. Here's why

The Imagion Biosystems Ltd share price is up 38% today following an update on its MagSense HER2 breast cancer study. Here's what the company announced.

| More on:
rising medical asx share price represented by excited doctors dancing in ward

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Imagion Biosystems Ltd (ASX: IBX) share price is rebounding strongly after weeks of severe falls. This comes after the company provided an update on its MagSense HER2 breast cancer study.

During mid-afternoon trade, the biotechnology and nanotechnology company's shares are 38.3% higher to 13 cents.

What was announced?

According to its release, Imagion advised that it has enrolled its first patient in the MagSense HER2 breast cancer Phase I first-in-human study.

The program aims to investigate the use of a MagSense imaging agent to increase the accuracy in detecting a patient's HER2 breast cancer. More specifically, the nanotechnology looks to see if the tumour has spread to the patient's lymph nodes.

Traditionally, the current standard of care involves a biopsy or surgical removal of the lymph nodes to confirm metastases. Approximately half of HER2 breast cancer patients have no nodal disease. Furthermore, this allows MagSense to provide non-invasive procedures in detecting cancer.

Each patient in the study receives an injection of the MagSense nanoparticle imaging agent and undergoes imaging by MRI. While this occurs, a sample of the lymph node is also assessed using the MagSense magnetic relaxometry technology.

Imagion is expecting to enrol a total of 15 participants in the phase 1 study. The aim of the program is to determine the safety and tolerability of the MagSense imaging agent. Furthermore, the company is also exploring the effectiveness of the nanoparticles for in vivo detection.

Imagion Biosystems executive chair, Bob Proulx commented:

We are very pleased to report our first patient has been enrolled in this ground-breaking study. Though recruiting newly diagnosed cancer patients into a research study can be challenging, we and our investigators remain confident we will reach our recruitment target. We are committed to explore all avenues to achieve our goal of completing this important study.

Imagion share price summary

Over the past 12 months, Imagion shares have gained more than 360%, but have fallen 10% on year-to-date performance. The company's share price reached an all-time high of 22.5 cents earlier this year.

Based on valuation metrics, Imagion commands a market capitalisation of roughly $135 million, with over $1 billion shares outstanding.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Market up or down
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the week...

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Share Gainers

4 ASX 200 shares racing ahead of the benchmark this week

ASX investors sent these four stocks soaring 12% to 18% this week. But why?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why BHP, Coronado Global, EBR Systems, and Whitehaven Coal shares are pushing higher today

These shares are ending the week on a positive note. Let's find out why.

Read more »

a young woman looks happily at her phone in one hand with a selection of shopping bags in her other hand.
BNPL shares

Up 87% since April, why the Zip share price can keep flying higher into 2026

A leading fund manager expects more outsized gains from Zip shares ahead.

Read more »

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a miserly session for investors today.

Read more »

Happy coal miner.
Share Gainers

Up 75% this week, why is this ASX All Ords stock rocketing again today?

Investors are piling into this ASX 300 stock on Wednesday. But why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a bountiful session for investors this hump day.

Read more »

Man looking happy and excited as he looks at his mobile phone.
Share Gainers

Why Coronado, DroneShield, Lovisa, and Mayne Pharma shares are racing higher today

These shares are having a good time on hump day. But why?

Read more »